Tag: AI in bioinformatics market insights

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The AI In Bioinformatics Market?

The AI in bioinformatics market has shown remarkable expansion in recent years. Its value is anticipated to rise from $4.3 billion in 2024 to $6.14 billion in 2025, reflecting a compound annual growth rate (CAGR) of 42.9%. This past growth can be ascribed to several contributing factors, such as the expanded availability of genomic data, the emergence of precision medicine, the necessity for biomarker discovery, advancements in clinical trial optimization, and heightened collaborative efforts.

The AI in bioinformatics market is projected to experience substantial growth over the coming years. Its valuation is anticipated to reach $26.15 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 43.7%. This expansion during the forecast period is driven by factors such as the proliferation of single-cell technologies, increasing focus on multi-omics integration, heightened emphasis on functional genomics, accelerated drug repurposing efforts, and wider incorporation of AI in pathology. Key developments expected within this period involve ethical AI and responsible data practices, the emergence of AI-driven virtual laboratories, the integration of quantum computing, the implementation of AI-powered clinical trials, and the use of blockchain for secure data sharing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

Which Drivers Are Shaping The AI In Bioinformatics Industry’s Market Share?

The anticipated expansion of AI in the bioinformatics market is projected to be driven by the rising count of clinical trials. Clinical trials are defined as a methodical and meticulously planned medical research endeavor engaging human subjects to assess the safety, effectiveness, and efficiency of novel medical interventions, therapies, drugs, devices, or strategic treatments. Within clinical trials, AI in bioinformatics analyzes patient information from electronic health records and various sources to pinpoint suitable candidates meeting specific criteria, thereby enhancing recruitment efficacy and precision. For instance, data from May 2023, provided by Xtalks, a Canada-based life science and medical device platform, revealed that ClinicalTrials.gov had 452,604 clinical trials registered globally as of May 2023, with 64,838 of these actively recruiting participants. This figure marks a significant increase from the over 365,000 trials reported at the beginning of 2021. Consequently, the escalating volume of clinical trials is fueling the expansion of AI in the bioinformatics market.

What Are The Different Segment Classifications Within The AI In Bioinformatics Market?

The ai in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

Which Market Trends Are Creating New Opportunities In The AI In Bioinformatics Industry?

Leading companies operating within the AI in bioinformatics market are advancing technological innovations via the Bionl.AI platform to boost their market profitability. Bionl.AI provides a consolidated workspace for exploration, analysis, and visualization, effectively reducing the duration needed for complex tasks from several days to mere minutes. For example, in October 2023, Bionl Inc., a US-based firm specializing in biomedical and bioinformatics research platforms, introduced Bionl.AI, a groundbreaking platform designed to transform biomedical and bioinformatics research by offering a no-code solution for researchers, students, and professionals to investigate biomedicine through natural language inquiries. The platform utilizes advanced GenAI models to facilitate immediate insights, rendering intricate analysis both approachable and engaging.

Which Major Firms Are Strengthening Their Position In The AI In Bioinformatics Industry?

Major companies operating in the AI in bioinformatics market report are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Illumina Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., SourceBio International Limited, Fios Genomics Limited, CelbridgeScience, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

How Is AI In Bioinformatics Market Demand Varying Across Different Regions?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The AI In Bioinformatics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp

Browse Through More Reports Similar to the Global AI In Bioinformatics Market 2025, By The Business Research Company

Ai In Clinical Trials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Ai In Energy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-energy-global-market-report

Ai In Medical Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-medical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the AI In Bioinformatics Sector?

In recent times, the market size for AI in bioinformatics has experienced exponential growth. The projected growth is from $4.3 billion in 2024 to $6.14 billion in 2025, having a compound annual growth rate (CAGR) of 42.9%. The historical growth period was driven by factors such as enhanced accessibility to genomic data, the emergence of precision medicine, a surge in the demand for biomarker discovery, optimization of clinical trials, and heightened collaborative efforts.

Expectations are high for escalating growth in the AI in bioinformatics market size over the coming years. The market is projected to expand to “$26.15 billion by 2029, growing at a compound annual growth rate (CAGR) of 43.7%”. This anticipated growth over the forecast period can be ascribed to the advancement of single-cell technologies, an increased emphasis on the integration of multi-omics, a rising focus on functional genomics, and an acceleration of drug repurposing as well as a surge in the utilisation of AI in pathology. Key trends to watch during the forecast period include a focus on ethical AI and responsible data usage, the development of AI-driven virtual labs, an integration of quantum computing, AI-boosted clinical trials, and the use of blockchain for the secure exchange of data.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

What Forces Are Driving The Growth Of The AI In Bioinformatics Market?

The surge in clinical trial numbers is projected to fuel the expansion of AI in the bioinformatics market. Clinical trials are a meticulously structured method of performing medical research which involves human subjects to assess the safety, efficacy, and potency of new healthcare interventions, treatments, medication, apparatus, or therapeutic tactics. AI in bioinformatics is deployed in these trials to scrutinize patient data acquired from electronic health histories and other resources to determine probable contenders for clinical trials who conform to certain criteria, thereby refining effectiveness of recruitment and specificity. For instance, as reported by Xtalks, a life science and medical apparatus platform based in Canada, in May 2023, ClinicalTrials.gov registered 452,604 clinical trials worldwide, and of these, 64,838 are actively searching for participants. Furthermore, compared to the more than 365,000 registered at the commencement of 2021, registered trials have seen a significant rise. As a result, the escalation in clinical trials is facilitating the progress of AI in the bioinformatics market.

The ai in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

What Trends Are Currently Influencing Growth In The AI In Bioinformatics Market?

Companies that are key players in the AI in bioinformatics market are utilizing technological advancements on the Bionl.AI platform to enhance their market profitability. Bionl.AI provides a comprehensive workspace for exploration, analysis, and visualization, significantly reducing the time needed to undertake complex tasks. For example, in October 2023, Bionl Inc., an American company specializing in biomedical and bioinformatics research platforms, introduced Bionl.AI. This innovative platform is designed to transform biomedical and bioinformatics research by offering a no-code solution for researchers, students, and professionals to delve into biomedicine using natural language queries. The platform uses advanced GenAI models to provide immediate insights and simplifies complex analysis, making it more interactive and user-friendly.

Which Companies Currently Dominate The Competitive Landscape In The AI In Bioinformatics Industry?

Major companies operating in the AI in bioinformatics market report are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Illumina Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., SourceBio International Limited, Fios Genomics Limited, CelbridgeScience, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

Which Geographic Regions Are Driving Demand In The AI In Bioinformatics Market?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the AI In Bioinformatics Market Size From 2025 to 2034?

The market size for AI in bioinformatics has witnessed significant expansion in the recent past. There’s set to be an elevation from $4.3 billion in 2024 to a whopping $6.14 billion in 2025, at a compound annual growth rate (CAGR) of 42.9%. Factors propelling growth during the historic period include the enhanced accessibility of genomic data, the emergence of precision medicine, the call for biomarker discovery, optimizations in clinical trials, and heightened collaboration.

The market size for AI in bioinformatics is projected to experience significant growth in the coming years, expecting to reach a massive $26.15 billion by the year 2029, with a compound annual growth rate (CAGR) of 43.7%. This predicted expansion during the forecast period is largely due to the increased use of single-cell technologies, a rising interest in integrating multi-omics, growing focus on functional genomics, fast-track repurposing of drugs and the increased application of AI in pathology. Key trends during this period will likely revolve around ethical AI practices and responsible data usage, the adoption of AI in virtual labs, the integration of quantum computing, AI-guided clinical trials, and utilising blockchain for secure data sharing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

What Are the Core Market Drivers Propelling Growth in the AI In Bioinformatics Industry?

The uptick in clinical trials is anticipated to drive the expansion of AI in the bioinformatics sector moving forward. Clinical trials, a meticulously organized and systematic method of undertaking medical investigations involving humans, assess the safety, efficiency, and performance of new healthcare interventions, treatments, drugs, devices, or therapeutic techniques. Bioinformatics AI is utilized in clinical trials to evaluate patient details from electronic health records and other data resources to pinpoint appropriate participants for clinical trials that fulfill certain criteria, boosting recruitment productivity and precision. For example, Xtalks, a Canada-based medical device and life science platform, reported in May 2023 that there were 452,604 globally registered clinical trials on ClinicalTrials.gov, with 64,838 of these studies actively seeking participants. Moreover, the count of registered trials has seen a notable surge from over 365,000 recorded at the start of 2021. Hence, the rise in clinical trials is powering the growth of AI in the bioinformatics market.

How Is the AI In Bioinformatics Market Segmented?

The ai in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp

Which Regions Are Driving the Next Phase of the AI In Bioinformatics Market Growth?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the AI In Bioinformatics Industry?

Leading enterprises in the AI in bioinformatics market are harnessing advancements in technology via the Bionl.AI platform, to bolster their market profitability. Bionl.AI serves as a comprehensive workspace that simplifies exploration, analysis, and visualization processes, significantly reducing the time needed for complex tasks from several days to mere minutes. For instance, in October 2023, US-based Bionl Inc., a firm specializing in biomedical and bioinformatics research, unveiled Bionl.AI. This innovative platform seeks to transform biomedical and bioinformatics research by offering a code-free solution for researchers, students, and professionals to explore biomedicine through the use of natural language queries. The platform utilizes cutting-edge GenAI models to facilitate immediate insights and simplify complex analysis procedures, making them more engaging.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

How Is the AI In Bioinformatics Market Defined and What Are Its Core Parameters?

AI in Bioinformatics refers to the application of artificial intelligence (AI) techniques and algorithms to analyze and interpret biological data. Bioinformatics involves the management and analysis of large and complex biological datasets, such as genomic sequences, protein structures, and other biological information.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13774

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Key Projections for the CAGR of the AI In Bioinformatics Market Size From 2025 to 2034?#_x000D_

The market size for AI in bioinformatics has witnessed significant expansion in the recent past. There’s set to be an elevation from $4.3 billion in 2024 to a whopping $6.14 billion in 2025, at a compound annual growth rate (CAGR) of 42.9%. Factors propelling growth during the historic period include the enhanced accessibility of genomic data, the emergence of precision medicine, the call for biomarker discovery, optimizations in clinical trials, and heightened collaboration._x000D_

_x000D_

The market size for AI in bioinformatics is projected to experience significant growth in the coming years, expecting to reach a massive $26.15 billion by the year 2029, with a compound annual growth rate (CAGR) of 43.7%. This predicted expansion during the forecast period is largely due to the increased use of single-cell technologies, a rising interest in integrating multi-omics, growing focus on functional genomics, fast-track repurposing of drugs and the increased application of AI in pathology. Key trends during this period will likely revolve around ethical AI practices and responsible data usage, the adoption of AI in virtual labs, the integration of quantum computing, AI-guided clinical trials, and utilising blockchain for secure data sharing._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the AI In Bioinformatics Industry?#_x000D_

The uptick in clinical trials is anticipated to drive the expansion of AI in the bioinformatics sector moving forward. Clinical trials, a meticulously organized and systematic method of undertaking medical investigations involving humans, assess the safety, efficiency, and performance of new healthcare interventions, treatments, drugs, devices, or therapeutic techniques. Bioinformatics AI is utilized in clinical trials to evaluate patient details from electronic health records and other data resources to pinpoint appropriate participants for clinical trials that fulfill certain criteria, boosting recruitment productivity and precision. For example, Xtalks, a Canada-based medical device and life science platform, reported in May 2023 that there were 452,604 globally registered clinical trials on ClinicalTrials.gov, with 64,838 of these studies actively seeking participants. Moreover, the count of registered trials has seen a notable surge from over 365,000 recorded at the start of 2021. Hence, the rise in clinical trials is powering the growth of AI in the bioinformatics market._x000D_

_x000D_

#How Is the AI In Bioinformatics Market Segmented?#_x000D_

The ai in bioinformatics market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Machine Learning, Deep Learning, Other Types_x000D_

2) By Offering: Services, Software_x000D_

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning _x000D_

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs) _x000D_

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the AI In Bioinformatics Market Growth?#_x000D_

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the AI In Bioinformatics Industry?#_x000D_

Leading enterprises in the AI in bioinformatics market are harnessing advancements in technology via the Bionl.AI platform, to bolster their market profitability. Bionl.AI serves as a comprehensive workspace that simplifies exploration, analysis, and visualization processes, significantly reducing the time needed for complex tasks from several days to mere minutes. For instance, in October 2023, US-based Bionl Inc., a firm specializing in biomedical and bioinformatics research, unveiled Bionl.AI. This innovative platform seeks to transform biomedical and bioinformatics research by offering a code-free solution for researchers, students, and professionals to explore biomedicine through the use of natural language queries. The platform utilizes cutting-edge GenAI models to facilitate immediate insights and simplify complex analysis procedures, making them more engaging._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report_x000D_

_x000D_

#How Is the AI In Bioinformatics Market Defined and What Are Its Core Parameters?#_x000D_

AI in Bioinformatics refers to the application of artificial intelligence (AI) techniques and algorithms to analyze and interpret biological data. Bioinformatics involves the management and analysis of large and complex biological datasets, such as genomic sequences, protein structures, and other biological information._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13774_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the AI In Bioinformatics Market Growth in 2025?

The market size of AI in bioinformatics has seen a phenomenal growth in the last few years, expected to inflate from $4.3 billion in 2024 to $6.18 billion in 2025, boasting a compound annual growth rate (CAGR) of 43.8%. The surge observed in the historic period can be linked to the expanding genomic data availability, emergence of precision medicine, escalating demand for biomarker discovery and clinical trial optimization, in addition to the rising tendency for increased collaboration.

What Is the Forecast for the AI In Bioinformatics Market Size Through 2029?

The market size of AI in bioinformatics is anticipated to witness an extraordinary growth in the coming years, with an estimated value of $26.46 billion in 2029, registering a compound annual growth rate (CAGR) of 43.9%. The primary factors contributing to this expected growth during the forecast period include the advancements in single-cell technologies, increased focus on the integration of multi-omics, a heightened emphasis on functional genomics, speed-up in drug repurposing, and broader acceptance of AI in pathology. Additionally, the period is likely to see major trends like AI ethics and responsible use of data, the emergence of AI-driven virtual labs, inclusion of quantum computing, initiation of AI-dominated clinical trials, and the application of blockchain technology for secure exchange of data.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

What are the Key Market Players in AI In Bioinformatics Market and How They’re Evolving?

Major companies operating in the AI in bioinformatics market report are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Illumina Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., SourceBio International Limited, Fios Genomics Limited, CelbridgeScience, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.

What Are the Primary Growth Drivers in the AI In Bioinformatics Market?

The growth of AI in the bioinformatics market is anticipated to accelerate due to the rising number of clinical trials. These trials involve a systematic, meticulously-planned procedure of medical research, which includes human participants to assess the safety and effectiveness of new medical treatments, drugs, devices, or therapeutic strategies. In these trials, AI in bioinformatics helps analyze patient data from electronic health records and other sources and identify potential candidates for clinical trials that meet certain criteria, enhancing recruitment efficiency and targeting. For instance, based on data from Xtalks, a Canada-based life science, and medical device firm cited on ClinicalTrials.gov, in May 2023, 452,604 clinical trials were registered globally, with 64,838 of the total registered studies actively seeking participants. There has been a significant rise in number of registered trials from over 365,000 reported at the beginning of 2021, indicating the growth of AI in the bioinformatics market driven by the increasing number of clinical trials.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp

What Are the Leading Segments in the Global AI In Bioinformatics Industry?

The AI in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

What Are the Key Market Trends in the AI In Bioinformatics Industry?

Key players in the AI in bioinformatics market are introducing technological enhancements to the Bionl.AI platform to boost their market earnings. Bionl.AI provides a comprehensive workspace for exploration, analysis, and visualization, drastically reducing the time taken to complete complex tasks. For instance, in October 2023, Bionl Inc., a company specializing in biomedical and bioinformatics research, debuted Bionl.AI. This groundbreaking platform seeks to transform biomedical and bioinformatics research by offering a no-code solution that allows researchers, students, and professionals to explore biomedicine through natural language queries. The platform employs advanced GenAI models to provide immediate insights and to make complicated analysis engaging and easier to handle.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

What Is the Regional Outlook for the AI In Bioinformatics Market?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13774

This Report Delivers Insight On:

1. How big is the ai in bioinformatics market, and how is it changing globally?

2. Who are the major companies in the ai in bioinformatics market, and how are they performing?

3. What are the key opportunities and risks in the ai in bioinformatics market right now?

4. Which products or customer segments are growing the most in the ai in bioinformatics market?

5. What factors are helping or slowing down the growth of the ai in bioinformatics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the ai in bioinformatics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the AI In Bioinformatics Market Size from 2025 to 2034?

The market size for AI in bioinformatics has seen a substantial increase in recent times. The market, valued at $4.3 billion in 2024, is set to escalate to $6.18 billion in 2025, exhibiting a 43.8% compound annual growth rate (CAGR). The significant growth during the historic span can be linked to the surge in genomic data accessibility, the emergence of precision medicine, an upward demand for biomarker discovery, improvements in clinical trial optimization, and enhanced collaborations.

In the coming years, significant expansion is anticipated in the AI in bioinformatics market, with projections suggesting an increase to $26.46 billion in 2029, a CAGR of 43.9%. This predicted surge during the forecasted span can be credited to the growth of single-cell technologies, a stronger emphasis on the integration of multi-omics, a heightened attention to functional genomics, the hastened repurposing of drugs, and the increased utilization of AI in pathology. Key trends forecasted include the ethical use of AI and responsible data handling, the advent of AI-controlled virtual labs, the merging of quantum computing, AI-facilitated clinical trials, and the application of blockchain for assured secure data exchange.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

Which Factors and External Forces Are Driving Demand in the AI In Bioinformatics Market?

Advancements in AI in the bioinformatics market are being pushed forward by the growing count of clinical trials. Clinical trials, which involve human participants in thoroughly planned medical research processes to ascertain the safety and effectiveness of new medications, treatments, or therapeutic methods, use AI in bioinformatics for data analysis. This technology is applied to scrutinize patient data gleaned from electronic health records and other sources. The aim is to pinpoint suitable candidates who meet particular criteria for these trials, thereby enhancing targeted recruitment and efficiency. In May 2023, Xtalks, a Canadian platform for life science and medicinal devices, cited ClinicalTrials.gov to state that of the 452,604 clinical trials registered globally, 64,838 are actively pursuing participants. The number of registered trials saw a significant rise from just over 365,000 reported early in 2021. Consequently, this surge in clinical trials is spurring on AI growth in the bioinformatics market.

Which Segments in the AI In Bioinformatics Offer the Most Growth?

The AI in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp

What Are the Fastest-Growing Geographies in the AI In Bioinformatics Market?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the AI In Bioinformatics Market’s Growth?

Leading firms in the AI in bioinformatics market are leveraging technological advancements on the Bionl.AI platform to boost their market profitability. The Bionl.AI platform provides a comprehensive workspace for experimentation, analysis, and visualization, significantly reducing the time needed to accomplish intricate tasks. For example, in October 2023, Bionl Inc., an American biomedical and bioinformatics research platform firm, unveiled Bionl.AI, an innovative platform designed to transform biomedical and bioinformatics research. It offers a no-code solution that enables researchers, students, and professionals to study biomedicine through natural language inquiries. This platform utilizes the latest GenAI models to provide immediate insights and simplify complex analyses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

What Are the Key Elements That Define the AI In Bioinformatics Market?

AI in Bioinformatics refers to the application of artificial intelligence (AI) techniques and algorithms to analyze and interpret biological data. Bioinformatics involves the management and analysis of large and complex biological datasets, such as genomic sequences, protein structures, and other biological information.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13774

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theAI In Bioinformatics Market?

The growth of AI in the bioinformatics market is likely to be spurred by the rise in the number of clinical trials. Clinical trials, which entail a meticulously planned process of conducting medical research involving humans, are used to ascertain the safety and effectiveness of new medical interventions, treatments, drugs, devices, or therapeutic strategies. AI is utilized in bioinformatics for clinical trials to analyze data from electronic health records and other sources, identifying suitable candidates for the trials based on specific criteria, thereby enhancing the efficacy of recruitment and targeting. For instance, as of May 2023, there were 452,604 registered clinical trials worldwide on ClinicalTrials.gov, according to Xtalks, a life science and medical device platform based in Canada, and out of these, 64,838 studies are actively in search for participants. The number of registered trials has also witnessed a significant surge from just over 365,000 reported in early 2021. Accordingly, the escalating number of clinical trials is stimulating the expansion of AI in the bioinformatics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

#What is the Projected CAGR for the AI In Bioinformatics Market Size from 2025 to 2034?

The market size of AI in bioinformatics has witnessed a substantial expansion in the past few years. It is expected to rise from $4.3 billion in 2024 to $6.18 billion in 2025, reflecting a compound annual growth rate (CAGR) of 43.8%. Factors contributing to such growth during the historical period include the surge in genomic data, the advent of precision medicine, the need for biomarker discovery, optimization of clinical trials, and enhanced collaboration.

In the forthcoming years, the market size of AI in bioinformatics is predicted to witness a dramatic surge, escalating to $26.46 billion in 2029 with a compound annual growth rate (CAGR) of 43.9%. The notable expansion during the prediction period can be related to the advancement of single-cell technologies, rising prioritization on multi-omics integration, increased concentration on functional genomics, quickening of drug repurposing, and a surge in the application of AI in pathology. Some key trends within this projected period encompass ethical usage of AI and responsible data handling, AI-facilitated virtual labs, the inclusion of quantum computing, AI-enabled clinical trials, and the use of blockchain for protected data exchange.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13774

Which Cutting-Edge Market Trends Are Expected to Drive theAI In Bioinformatics Market’s Growth?

Leading firms in the AI in bioinformatics market are making use of the Bionl.AI platform to introduce radical technological improvements to boost their market profits. Bionl.AI is a comprehensive workspace that simplifies exploration, analysis, and visualization, significantly reducing the time needed for complicated processes. In October 2023, Bionl Inc., a biomedical and bioinformatics research platform company based in the US, unveiled Bionl.AI. This innovative platform is designed to transform biomedical and bioinformatics research by offering a no-code option for research, education, and profession, enabling exploration of biomedicine through natural language queries. The platform utilizes cutting-edge GenAI models to provide immediate insights, allowing complex analysis to become accessible and interactive.

What Are the Leading Market Players Impacting theAI In Bioinformatics Market’s Growth Trend?

Major companies operating in the AI in bioinformatics market report are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Illumina Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., SourceBio International Limited, Fios Genomics Limited, CelbridgeScience, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

How Are the Key Segments of the AI In Bioinformatics Market Driving Opportunities and Innovations?

The AI in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13774&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theAI In Bioinformatics Market?# Market Expansion?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global AI In Bioinformatics Market 2025, By The Business Research Company:

AI In Clinical Trials Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Artificial Intelligence (AI) Chipsets Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-chipsets-global-market-report

AI-Powered Storage Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-powered-storage-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the ai in bioinformatics market size evolved in recent years?

The market size of AI in bioinformatics has been experiencing rapid expansion in the past few years. Its expected growth will range from $4.3 billion in 2024 to $6.18 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 43.8%. Factors contributing to this growth during the historical window include the proliferation of genomic data, the emergence of precision medicine, the need for biomarker discovery, optimization of clinical trials, and a rise in collaborative efforts.

What are the predictions for the ai in bioinformatics market size in the coming years?

Expectations are high for an exponential surge in the AI in bioinformatics market size within the next several years. Predictions indicate a growth to $26.46 billion by 2029, with a 43.9% compound annual growth rate (CAGR). The anticipated growth during the projected period can be traced back to the broadening of single-cell technologies, heightened focus on multi-omics integration, increasing attention on functional genomics, ramping up of drug repurposing, and a rising trend in applying AI in pathology. Leading trends projected for the period cover ethical use of AI and responsible data handling, the rise of AI-aided virtual labs, incorporation of quantum computing, AI-enhanced clinical trials, and the use of blockchain for secured data exchange.

Get your ai in bioinformatics market report here!

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

What key factors are fueling the growth of the ai in bioinformatics market?

The growth of AI in the bioinformatics market is anticipated to be driven by the rising number of clinical trials. Clinical trials, the meticulously designed process of conducting medical research involving humans to assess the safety, effectiveness, and efficiency of novel medical interventions, treatments, drugs, devices, or therapeutic strategies, are making use of AI in bioinformatics. The technology is utilized to scrutinize patient data from electronic health records and other sources for identifying likely participants for these trials who fulfill particular criteria, thus enhancing the efficacy of recruitment and targeting. As per a report by Xtalks, a Canadian life sciences and medical device platform, in May 2023, there were a total of 452,604 registered clinical trials worldwide on ClinicalTrials.gov, out of which, 64,838 trials were actively searching for participants. The figures indeed underscore a marked surge from the approximately 365,000 trials documented at the start of 2021. As a result, the escalating number of clinical trials is stimulating the growth of AI in the bioinformatics market.

How is the global ai in bioinformatics market divided into key segments?

The AI in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

Who are the key firms paving the way for growth in the ai in bioinformatics market?

Major companies operating in the AI in bioinformatics market report are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Illumina Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., SourceBio International Limited, Fios Genomics Limited, CelbridgeScience, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.

Which trends are expected to transform the ai in bioinformatics market?

Key players in the AI bioinformatics market are utilizing innovative technologies on the Bionl.AI platform to enhance their profit margins. This platform is a comprehensive workspace that simplifies exploration, analysis, and visualization, significantly reducing the time needed for complex tasks. For example, in October 2023, Bionl Inc., a US-based company specializing in biomedical and bioinformatics research, introduced Bionl.AI. This trailblazing platform is set to transform biomedical and bioinformatics research by offering a no-code solution enabling researchers, students, and professionals to examine biomedicine through natural language queries. Through the use of advanced GenAI models, the platform facilitates instant insights and simplifies complex analyses, making them both accessible and engaging.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13774

What regions are contributing significantly to the growth of the ai in bioinformatics market?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

AI In Clinical Trials Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Artificial Intelligence (AI) Chipsets Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-chipsets-global-market-report

AI-Powered Storage Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-powered-storage-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the AI In Bioinformatics Market Grow Over the Forecast Period Based on Its Expected CAGR?

The market size for AI in bioinformatics has seen a significant increase over the recent years. It is projected to expand from $4.3 billion in 2024 to a sizeable $6.18 billion in 2025, representing a compound annual growth rate (CAGR) of 43.8%. This substantial expansion during the historical period can be accredited to factors like improved availability of genomic data, emergence of precision medicine, the need for biomarker discovery, optimization in clinical trials and enhanced collaborations.

Anticipated to see robust growth in the upcoming years, the AI in bioinformatics market is predicted to expand significantly, reaching $26.46 billion in 2029 with a compound annual growth rate (CAGR) of 43.9%. The surge during the forecast period is largely due to the broader incorporation of single-cell technologies, increased focus on the integration of multi-omics, heightened interest in functional genomics, fast pacing of drug repurposing, and the growing use of AI in pathology. Key trends in this forecast period encompass ethical AI and responsible usage of data, AI-propelled virtual laboratories, incorporation of quantum computing, AI fuelled clinical trials, and utilization of blockchain for guaranteed secure data exchange.

What Strategic Factors Are Influencing the Accelerated Growth of the ai in bioinformatics Market?

Growth in the bioinformatics market, specifically in regard to AI, is anticipated to be fueled by the escalating amount of clinical trials. Clinical trials are a meticulously structured procedure of conducting medical research with human participants, with an aim of assessing the safety and effectiveness of new medical interventions, treatments, drugs, devices, or therapeutic strategies. The role of AI in bioinformatics within these trials is to analyze patient data, sourced from electronic health records and other platforms, in order to identify suitable candidates for clinical trials, thereby enhancing recruitment efficacy and precision. For instance, a report by Xtalks, a life science and medical device platform based in Canada, revealed that as of May 2023, of the 452,604 clinical trials registered worldwide on ClinicalTrials.gov, 64,838 are actively in search of participants. It’s worthy of noting that, there’s been a significant surge in the number of registered trials since the beginning of 2021 where the total was over 365,000. Consequently, the rise in clinical trials is propelling the growth of AI in the bioinformatics market.

Request Your Free AI In Bioinformatics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

Who Are the Dominant Players Expanding Their Reach in the AI In Bioinformatics Market?

Major companies operating in the AI in bioinformatics market report are:

• Thermo Fisher Scientific Inc._x000D_

• Eurofins Scientific SE_x000D_

• Dassault Systèmes SE_x000D_

• Illumina Inc._x000D_

• NeoGenomics Laboratories Inc._x000D_

What Are the Top Trends Shaping the Evolution of the AI In Bioinformatics Market?

Key players in the AI in bioinformatics market are utilizing advanced technology with the Bionl.AI platform to boost their profitability. Bionl.AI functions as a comprehensive workspace for exploration, analysis, and visualization, notably reducing the time taken to finish intricate tasks from days to mere minutes. For example, in October 2023, Bionl Inc., an American company focused on biomedical and bioinformatics research, introduced Bionl.AI. This ground-breaking platform seeks to transform biomedical and bioinformatics research, offering a user-friendly solution for researchers, students, and professionals to delve into biomedicine via natural language queries. The highly sophisticated GenAI models employed by this platform facilitate immediate insights and simplify complex analysis, making it interactive and manageable.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

Which Key Segments of the AI In Bioinformatics Market Are Poised for Growth and Innovation?

The AI in bioinformatics market covered in this report is segmented –

1) By Type: Machine Learning, Deep Learning, Other Types

2) By Offering: Services, Software

3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications

Subsegments:

1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning

2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs)

3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems

Which Regions Are Setting the Pace for AI In Bioinformatics Market Growth?

North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the AI In Bioinformatics Market?

AI in Bioinformatics refers to the application of artificial intelligence (AI) techniques and algorithms to analyze and interpret biological data. Bioinformatics involves the management and analysis of large and complex biological datasets, such as genomic sequences, protein structures, and other biological information.

Browse Through More Similar Reports By The Business Research Company:

AI In Clinical Trials Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Artificial Intelligence (AI) Chipsets Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-chipsets-global-market-report

AI-Powered Storage Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-powered-storage-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: